Literature DB >> 10584591

Fomepizole (4-methylpyrazole) in fatal methanol poisoning with early CT scan cerebral lesions.

C Girault1, F Tamion, F Moritz, F Callonnec, J M Droy, G Bonmarchand, J Leroy.   

Abstract

BACKGROUND: Methanol poisoning, potentially fatal, is generally treated with the combination of ethanol as antidote, and hemodialysis. Fomepizole, a competitive inhibitor of alcohol dehydrogenase, has more recently been used, and is capable of blocking the toxic metabolism of methanol. To our knowledge, its use has never been reported as an antidote in severe methanol poisoning requiring hemodialysis. CASE REPORT: We report a case of fatal methanol poisoning (1.9 g/L on admission) suspected due to the combined presence of coma and severe metabolic acidosis with normokalaemia.
CONCLUSION: The fomepizole treatment protocol (10 mg/kg by i.v. infusion over 1 hour before dialysis, repeated 12 hours later in combination with 1.5 mg/kg/h during dialysis) was simple to use and appeared effective in eliminating methanol in combination with hemodialysis. The case is also unusual in terms of severity and the early onset of cerebral lesions demonstrated by computed tomography (CT) scan.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10584591     DOI: 10.1081/clt-100102456

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  3 in total

1.  Acute bilateral blindness caused by accidental methanol intoxication during fire "eating".

Authors:  C Cursiefen; A Bergua
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

2.  Case files of the California poison control system, San Francisco division: blue thunder ingestion: methanol, nitromethane, and elevated creatinine.

Authors:  Adeline Su-Yin Ngo; Freda Rowley; Kent R Olson
Journal:  J Med Toxicol       Date:  2010-03

3.  A systematic review of ethanol and fomepizole use in toxic alcohol ingestions.

Authors:  Lorri Beatty; Robert Green; Kirk Magee; Peter Zed
Journal:  Emerg Med Int       Date:  2013-01-31       Impact factor: 1.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.